Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
<p>Abstract</p> <p>Background</p> <p>New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence....
Saved in:
Main Authors: | Andersen John D (Author), Boylan Kristin LM (Author), Jemmerson Ronald (Author), Geller Melissa A (Author), Misemer Benjamin (Author), Harrington Katherine M (Author), Weivoda Starchild (Author), Witthuhn Bruce A (Author), Argenta Peter (Author), Vogel Rachel (Author), Skubitz Amy PN (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
by: Yonghui Zou, et al.
Published: (2022) -
Decreased expression of alpha-2-HS glycoprotein in the sera of rats treated with Eurycoma longifolia extract
by: Yeng eChen, et al.
Published: (2015) -
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
by: Tetsuhiro Yoshimura, et al.
Published: (2021) -
Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
by: Yuka Shibata, et al.
Published: (2021) -
Protein synthesis regulation by leucine
by: Daiana Vianna, et al.
Published: (2010)